SCHOOL OF MEDICINE
FIND PEOPLE AT PITT
Departmental Vice Chairs
Mission and History
Thomas E. Starzl BST
Biomedical Science Tower 3
Faculty Development Program
Equipment/IT Support Request
(pharmacology.us site search is temporarily unavailable)
Melanie S. Flint, PhD
Research Assistant Professor
Magee-Womens Research Institute - B430
204 Craft Avenue, Pittsburgh, PA 15213
412 641 2451
412 641 6156
BS (Biology), University of Portsmouth, England, 1993.
MS (Applied Toxicology), University of Portsmouth, England, 1994.
PhD (Biochemical Toxicology), Imperial College, University of London, England, 1998.
Postdoctoral Scientist, CDC/NIOSH, Morgantown, WV, 1998-2000.
Dr. Flint’s primary research project involves the direct interplay between stress hormones (cortisol, NE, and E), cancer and chemotherapy. This is accomplished through a mechanistic study of administration of stress hormones to cancerous cells, and observing these effects both in vitro and in rodent models. Currently, the focus of Dr Flint’s work is translational breast and ovarian cancer research. Specifically, her research examines hormonal influences on cell cycle regulation and cancer. There are two ongoing research projects which will endeavor to begin to fill a large gap in the literature and are readily translated to the clinic; 1) determine the mechanisms through which catecholamines and glucocorticoids affect DNA damage and repair mechanisms in breast cancer cells and to understand how these hormones affect the efficacy of chemotherapy agents with a focus on high risk BRCA mutation carriers (figure 1) and 2) examine the mechanisms of catecholamines and glucocorticoids on the adaptive immune system, and tumorigenesis using a genetic mouse model and a human cohort in ovarian cancer.
, A Baum, B Episcopo. KZ Knickelbein, AJ Liegey Dougall, WH Chambers and FJ Jenkins. Chronic exposure to sress hormones promotes transformation and tumorigenicity of 3T3 mouse fibroblasts. Stress 16:114-121, 2013.
and DH Bovbjerg. DNA damage as a result of psychological stress: Implications for breast cancer. Breast Cancer Res 14:320-322, 2012.
, RA Budiu, P Teng, M Sun, D Stolz, M Lang, AM Vlad, BL Hood and TP Conrads. Restraint stress and stress hormones significantly impact T lymphocyte migration and function through specific alterations of the actin cytoskeleton. Brain Behavior & Immunity 25:1187-1196, 2011.
Maxwell GL, BL Hood, R Day, U Chandran, D Kirchner, NW Bateman, J Allard, C Miller, M Sun,
, VS Kolli, C Zahn, J Oliver, S Banerjee, T Litzi, A Parwani, G Sandburg, S Rose, M Becich, A Berchuck, E Kohn, JI Risinger and TP Conrads. Proteomic analysis of Stage I endometrial cancer tissue: Identification of proteins associated with oxidative processes and inflammation. Gynecologic Oncology 1:121:586-594, 2011.
, K McCarty, F Jenkins, TP Conrads, M Sun and A Baum. Psychological stress accelerates the onset of tumour formation and alters the type and location of tumours in a DMBA mouse carcinogenesis model. Stress and Health 27:doi:10.1002/smi.1343.
Bateman NW, M Sun, BL Hood,
and TP Conrads. Defining central themes in breast cancer biology by differential proteomics: Conserved regulation of cell spreading and focal adhesion kinase. Journal of Proteome Research 9:5311-5324, 2010.
, BL Hood, M Sun, NA Stewart, J Jones-Laughner and TP Conrads. A proteomic analysis of the murine liver in response to a combined exposure to psychological stress and 7,12-dimethylbenz(a) anthracene. Journal of Proteome Research 9:509-520, 2010.
, NE Bateman, G Kim, BL Hood, NA Stewart and TP Conrads. Stress hormones mediate drug resistance to paclitaxel in human breast cancer cells through a Cdk-1 dependent pathway. Psychoneuroendocrinology 34:1533-1541, 2009.
Back to Top